A Peptide Analogue of Selectin Ligands Attenuated Atherosclerosis by Inhibiting Monocyte Activation
A Peptide Analogue of Selectin Ligands Attenuated Atherosclerosis by Inhibiting Monocyte Activation
复制标题
选择素配体的肽类似物通过抑制单核细胞活化减轻动脉粥样硬化
DOI:
10.1155/2019/8709583
复制
发表时间:
2019-05
影响因子:
4.6
通讯作者:
Huang Rongchong
中科院分区:
文献类型:
--
作者:
Ye Zhishuai;Zhang Shanfeng;Liu Yubo;Wang Shujing;Zhang Jianing;Huang Rongchong
Background Circulating monocytes play a critical role in the pathogenesis of atherosclerosis. Monocyte homing to sites of atherosclerosis is primarily initiated by selectin. Thus, blockade of the interaction of selectins and their ligands holds a significant role in monocyte homing which might be a potential approach to treat atherosclerosis. Here, we investigated the efficacy of a novel peptide analogue of selectin ligands IELLQAR in atherosclerosis. Methods and Results In this study, we firstly measured the effect of the IELLQAR selectin-binding peptide on the inhibition of binding of selectins to monocytes by flow cytometry, which exhibited a dose-dependent inhibitory effect on the binding of the P-, E-, and L-selectins to monocytes, especially the inhibition of P-selectin binding to human peripheral blood monocytes (PBMCs) (half maximal inhibitory concentration (IC50~5 μM)) and THP-1 cells (IC50~10 μM). Furthermore, IELLQAR inhibited P-selectin-induced activation of CD11b on the surface of monocytes and decreased adhesion of monocytes to the endothelium. ApoE−/− mice with or without IELLQAR (1 or 3 mg/kg) fed a Western-type diet (WTD) or which had disturbed blood flow-induced shear stress underwent partial left carotid artery ligation (PLCA) to induce atherosclerosis. In the WTD- and PLCA-induced atherosclerosis models, atherosclerotic plaque formation and monocyte/macrophage infiltration of the arterial wall both decreased in ApoE−/− mice treated with the IELLQAR peptide. Our results also revealed that IELLQAR inhibited the differentiation of monocytes into macrophages through P-selectin-dependent activation of the nuclear factor- (NF-) κB and mammalian target of rapamycin (mTOR) pathways. Conclusion Collectively, our results demonstrated that IELLQAR, a peptide analogue of selectin ligands, inhibited selectin binding to monocytes, which led to subsequent attenuation of atherosclerosis via inhibition of monocyte activation. Hence, use of the IELLQAR peptide provides a new approach and represents a promising candidate for the treatment of atherosclerosis in the early stage of disease.
登录
查看更多内容
DOI:
--
发表时间:
--
期刊:
--
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1136/bmj.323.7325.1375/a
发表时间:
2001-12
期刊:
BMJ : British Medical Journal
影响因子:
--
作者:
K. Barraclough
通讯作者:
K. Barraclough
影响因子:
6.7
作者:
Gremmel, Thomas;Koppensteiner, Renate;Panzer, Simon
通讯作者:
Panzer, Simon
DOI:
10.1017/cbo9781139207249.009
发表时间:
2012
期刊:
--
影响因子:
--
作者:
W. Marsden
通讯作者:
W. Marsden
DOI:
--
发表时间:
2005
期刊:
Journal of Jilin University
影响因子:
--
作者:
L. Qing
通讯作者:
L. Qing